Global Bioenergies: First significant sales in 2022
Retrieved on:
火曜日, 2月 14, 2023
The negative retained earnings balance was allocated to the share premium by resolution of the General Meeting of Shareholders on 2 June 2022.
Key Points:
- The negative retained earnings balance was allocated to the share premium by resolution of the General Meeting of Shareholders on 2 June 2022.
- This production was made possible by the roll-out of an entirely French chain, coordinated by Global Bioenergies.
- This step is carried out at the Pomacle unit, the construction and commissioning of which were two of the major objectives achieved by Global Bioenergies in 2022.
- Global Bioenergies’ Isonaturane® 12 stands out in the world of cosmetic ingredients for its particularly high selling price.